Calvin Lee

Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study

Joan T. Merrill, Ronald van Vollenhoven, Jill P. Buyon et al. · Annals of the Rheumatic Diseases · 2015 · 224 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Polatuzumab vedotin in combination with immunochemotherapy in patients with previously untreated diffuse large B-cell lymphoma: an open-label, non-randomised, phase 1b–2 study

Hervé Tilly, Franck Morschhauser, Nancy L. Bartlett et al. · The Lancet Oncology · 2019 · 139 citations · Full text

Medicine, Immunology, Oncology +9

Gastrointestinal bleeding in hospitalized COVID‐19 patients: a propensity score matched cohort study

Arvind J. Trindade, Stephanie Izard, Kevin Coppa et al. · Journal of Internal Medicine · 2020 · 65 citations

Medicine, Pharmacotherapy, Clinical Epidemiology +10

Safety and feasibility of performing peroral endoscopic myotomy as an outpatient procedure with same-day discharge

Petros C. Benias, Praneet Korrapati, Kara L. Raphael et al. · Gastrointestinal Endoscopy · 2019 · 56 citations

Medicine, Surgery, General Surgery +6

Magrolimab plus azacitidine vs physician’s choice for untreated <i>TP53</i>-mutated acute myeloid leukemia: the ENHANCE-2 study

Joshua F. Zeidner, David A. Sallman, Christian Récher et al. · Blood · 2025 · 55 citations · Full text

Medicine, Oncology, Pharmacotherapy +12